Plasma Levels of Angiotensin-Converting Enzymes 1 and 2 and <i>AGTR</i>2 (T1247G and A5235G) Gene Polymorphisms Are Associated to Breast Cancer Progression

作     者：Maria Del Carmen Garcia Molina Wolgien Ismael Dale Cotrim Guerreiro da Silva Afonso Celso Pinto Nazário Clovis Riyuchi Nakaie Silvana Aparecida Alves Corrêa de Noronha Samuel Marcos Ribeiro de Noronha Gil Facina 

作者机构：Biophisics Department Escola Paulista de Medicina da Universidade Federal de Sao Paulo (EPM-UNIFESP) Sao Paulo Brazil Gynecology Department Escola Paulista de Medicina/Universidade Federal de Sao Paulo (EPM-UNIFESP) Sao Paulo Brazil Surgery Department Escola Paulista de Medicina/Universidade Federal de Sao Paulo (EPM-UNIFESP) Sao Paulo Brazil 

出 版 物：《Journal of Cancer Therapy》 (癌症治疗（英文）)

年 卷 期：2013年第4卷第9期

页      面：1403-1410页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Angiotensin-Converting Enzyme 1 Angiotensin-Converting Enzyme 2 Angiotensin II Type 2 Receptor Breast Neoplasm ACEs Plasma Level Genetic Polymorphisms 

摘      要：Background: Breast cancer is the most common type of cancer among women. Diagnosed and treated timely, patients may have good prognostics. In Brazil, in 2012, the estimate of new cases was 52,680 and the number of registered deaths in 2012 was 12,852. The Renin-Angiotensin System (RAS) is known for its role in arterial hypertension and in other cardiovascular diseases. Angiotensin-Converting Enzyme 2 (ACE2) is the key to Ang-(1-7) formation, and counterbalances the ACE1/AngII/AGTR1 axis actions. RAS components have complex interactions with different tissues and their actions are not restricted to the cardiovascular system. Recently, the RAS has been associated with different types of cancers and in particular with gynecological cancers. Objectives: Our aim is to investigate possible associations between allelic distribution of two genetic polymorphisms in the AGTR2 receptor with ACEs 1 and 2 plasma levels among women with breast cancer. Patients and Methods: Patients with breast cancer were genotyped for two polymorphisms of the AGTR2 (T1247G and A5235G). Genotyping assays (TaqMan) were performed with genomic DNA extracted from blood cells. ACEs plasma level measurements were conducted in women from the breast-cancer group (N = 53). ACEs were measured in the plasma of these patients using ELISA kits. Results: SNPs genotype distribution is correlated with ACEs plasma levels. ACEs plasma levels are also correlated with clinical variables and ACE2 high levels are associated with better prognostics. Conclusions: Changes in circulating levels of ECA1/AngII ECA2/ Ang-(1-7) determine the magnitude of the inflammatory response that an individual can trigger and the variation in ACE 1 and 2 plasma level measurements in the blood of breast cancer patients suggests an association with the process of mammary carcinogenesis. Thus, the RAS may be associated with the process of mammary carcinogenesis by both genotypic variations of RAS components and by circulating levels of ACEs